Pulnovo completes $100m financing round with Medtronic investment

Pulnovo Medical has successfully completed an oversubscribed $100 million strategic financing round, with Medtronic as the lead investor. This funding will support clinical development, global regulatory submissions, international commercialization, and technology platform investments. Pulnovo also entered a commercial agreement with Medtronic to leverage its global infrastructure and strengthen market presence for Pulnovo’s pulmonary artery denervation (PADN) system.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin